Jacobs Solutions Inc. (J)

We recently published Jim Cramer's ... (NYSE:JNJ) is one of the stocks discussed by Jim Cramer. Healthcare giant Johnson & Johnson (NYSE:JNJ)'s shares are up by 68% over the past year and by 26% year-to-date. The firm reported its fourth quarter earnings on January 21st...

The stock trades at a forward price-to-earnings multiple of 33, reflecting the market’s optimism about the GLP-1 pipeline. Shares are up 56.86% over the past year. Yet warning signs are flashing. The company reported a 13% price decline on rebates, and that figure could widen as Mounjaro enters Chin…

JNJ will release its Q2 earnings on July 15, with analysts expecting earnings of $2.85 per share and revenue of $25.05 billion. Stock rose 3.6%.

The company pays a current dividend ... which JPMorgan analyst Anthony Paolone highlighted as a reason why EPR made the firm's list this month. "High dividend yield > 6% that we see as safe and growing, with earnings growth that is also likely to be toward the top of the net lease REIT peer group," …

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.Show More · When does JPMorgan Chase & Co.